Marissa B Esser1, Gery P Guy2, Kun Zhang2, Robert D Brewer3. 1. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: messer@cdc.gov. 2. Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
INTRODUCTION: Prescription opioids were responsible for approximately 17,000 deaths in the U.S. in 2016. One in five prescription opioid deaths also involve alcohol. Drinkers who misuse prescription opioids (i.e., use without a prescription or use only for the experience or feeling it causes) are at a heightened risk of overdose. However, little is known about the relationship between drinking patterns and prescription opioid misuse. METHODS: Data were analyzed from 160,812 individuals (aged ≥12 years) who responded to questions about prescription opioid misuse and alcohol consumption in the 2012, 2013, or 2014 National Survey on Drug Use and Health (analyzed in 2017-2018). The prevalence of self-reported past-30-days prescription opioid misuse was assessed by sociodemographic characteristics, other substance use (i.e., cigarettes, marijuana), and drinking patterns. Multiple logistic regression analyses were used to calculate AORs. RESULTS: From 2012 to 2014, 1.6% (95% CI=1.5, 1.7) of all individuals aged ≥12 years (estimated 4.2 million) and 3.5% (95% CI=3.3, 3.8) of binge drinkers (estimated 2.2 million) reported prescription opioid misuse. Prescription opioid misuse was more common among binge drinkers than among nondrinkers (AOR=1.7, 95% CI=1.5, 1.9). Overall, the prevalence of prescription opioid misuse increased significantly with binge drinking frequency (p-value<0.001). CONCLUSIONS: More than half of the 4.2 million people who misused prescription opioids during 2012-2014 were binge drinkers, and binge drinkers had nearly twice the odds of misusing prescription opioids, compared with nondrinkers. Widespread use of evidence-based strategies for preventing binge drinking might reduce opioid misuse and overdoses involving alcohol. Published by Elsevier Inc.
INTRODUCTION: Prescription opioids were responsible for approximately 17,000 deaths in the U.S. in 2016. One in five prescription opioid deaths also involve alcohol. Drinkers who misuse prescription opioids (i.e., use without a prescription or use only for the experience or feeling it causes) are at a heightened risk of overdose. However, little is known about the relationship between drinking patterns and prescription opioid misuse. METHODS: Data were analyzed from 160,812 individuals (aged ≥12 years) who responded to questions about prescription opioid misuse and alcohol consumption in the 2012, 2013, or 2014 National Survey on Drug Use and Health (analyzed in 2017-2018). The prevalence of self-reported past-30-days prescription opioid misuse was assessed by sociodemographic characteristics, other substance use (i.e., cigarettes, marijuana), and drinking patterns. Multiple logistic regression analyses were used to calculate AORs. RESULTS: From 2012 to 2014, 1.6% (95% CI=1.5, 1.7) of all individuals aged ≥12 years (estimated 4.2 million) and 3.5% (95% CI=3.3, 3.8) of binge drinkers (estimated 2.2 million) reported prescription opioid misuse. Prescription opioid misuse was more common among binge drinkers than among nondrinkers (AOR=1.7, 95% CI=1.5, 1.9). Overall, the prevalence of prescription opioid misuse increased significantly with binge drinking frequency (p-value<0.001). CONCLUSIONS: More than half of the 4.2 million people who misused prescription opioids during 2012-2014 were binge drinkers, and binge drinkers had nearly twice the odds of misusing prescription opioids, compared with nondrinkers. Widespread use of evidence-based strategies for preventing binge drinking might reduce opioid misuse and overdoses involving alcohol. Published by Elsevier Inc.
Authors: Jacqueline W Miller; Joseph C Gfroerer; Robert D Brewer; Timothy S Naimi; Ali Mokdad; Wayne H Giles Journal: Am J Prev Med Date: 2004-10 Impact factor: 5.043
Authors: Carla Alexia Campbell; Robert A Hahn; Randy Elder; Robert Brewer; Sajal Chattopadhyay; Jonathan Fielding; Timothy S Naimi; Traci Toomey; Briana Lawrence; Jennifer Cook Middleton Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043
Authors: Randy W Elder; Briana Lawrence; Aneeqah Ferguson; Timothy S Naimi; Robert D Brewer; Sajal K Chattopadhyay; Traci L Toomey; Jonathan E Fielding Journal: Am J Prev Med Date: 2010-02 Impact factor: 5.043
Authors: Veda Rammohan; Robert A Hahn; Randy Elder; Robert Brewer; Jonathan Fielding; Timothy S Naimi; Traci L Toomey; Sajal K Chattopadhyay; Carlos Zometa Journal: Am J Prev Med Date: 2011-09 Impact factor: 5.043
Authors: Monique M Cherrier; Danny D Shen; Laura Shireman; Andrew J Saxon; Tracy Simpson; Alex Men; Preetma Kooner; Gregory W Terman Journal: Pharmacol Biochem Behav Date: 2021-11-04 Impact factor: 3.533
Authors: Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule Journal: J Child Adolesc Psychopharmacol Date: 2022-05-04 Impact factor: 3.031
Authors: Marissa B Esser; Jeffrey J Sacks; Adam Sherk; Katherine J Karriker-Jaffe; Thomas K Greenfield; Carol Pierannunzi; Robert D Brewer Journal: Am J Prev Med Date: 2020-08-01 Impact factor: 5.043
Authors: Shanna Babalonis; Marion A Coe; Paul A Nuzzo; Michelle R Lofwall; Nur Ali; Paul A Sloan; Laura C Fanucchi; Sharon L Walsh Journal: Psychopharmacology (Berl) Date: 2020-11-09 Impact factor: 4.530
Authors: Naomi Greene; Marissa B Esser; Roumen Vesselinov; Kimberly M Auman; Timothy J Kerns; Margaret H Lauerman Journal: Am J Drug Alcohol Abuse Date: 2020-10-09 Impact factor: 3.829
Authors: Johannes Thrul; Beth A Reboussin; Jill A Rabinowitz; Brion S Maher; Nicholas S Ialongo Journal: Subst Abus Date: 2021-03-24 Impact factor: 3.716